8-K filed Jul 30, 2026 at 07:06 ET
Altria reported Q2 2026 adjusted diluted EPS of $1.48, a 2.8% YoY increase but a 1.3% miss vs. consensus of $1.50. Net revenues were essentially flat at $6.1B (+0.1% YoY), slightly above the $5.35B consensus. The company narrowed its full-year 2026 adjusted EPS guidance to $5.61-$5.72 (from $5.56-$5.72), raising the lower end. Smokeable segment adjusted OCI grew 2.4% on higher pricing, but oral tobacco segment adjusted OCI fell 8.0% on lower volume and higher promotions. The stock is likely to trade modestly lower on the EPS miss, partially offset by the narrowed guidance range.